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Background
Immune reconstitution inflammatory syndrome (IRIS) is
a common cause of death and even more common
cause of morbidity in patients started on highly active
antiretroviral therapy (HAART). At present, very limited
data is available about IRIS in the local population so the
present study was conducted to determine the incidence,
clinical manifestations, risk factors and outcomes of IRIS
in south Indian HIV/AIDS patients.
Methods
Study was a prospective surveillance method to identify
IRIS from two ART centers in Mysore city, India for a
period of two years. HIV patients who are initiated with
HAART were included for the study and were followed
up for a period of six months. Data were analyzed using
SPSS version 21.
Results
Out of 798 people followed 82 patients had experienced
IRIS with an incidence rate of 10%. Among them 48%
were unmasking and rest were paradoxical worsening.
Diagnosis included tuberculosis (44%), herpes zoster
(18%), cryptococcal meningitis (11%) and other opportu-
nistic infections (27%). The major manifestation of IRIS
were fever (44%) followed by lymphadenitis (36%). Sta-
tistically important predictors for occurrence of IRIS
were male gender and low CD4 count. Two deaths were
attributable to IRIS and 54% of them required
hospitalization.
Conclusion
Patients with advanced immunodeficiency at HAART
initiation are at greatest risk of developing IRIS and should
be appropriately screened and monitored. Educational
programs on recognizing and treating these conditions
should be initiated in ART access programs.
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